Member Info for Spikeyj

? …looks like someone trying to position for a pump & dump
on panoro / petronor news? - that’s presumably the event that
they will try to use to get a big placing done within the next 7-8
weeks (necessary, as otherwise ADME’s cash runs out by then).

? maybe he sobered up?

so maybe invest rather than trade?

think part of the issue is that oncology is a key area for AZN,
and anticipated setbacks to global economy /activity due to
omicron seen as likely to hit earnings from oncology treatments.

(inflationary pressures also not helping?)

stunning that this share is not suspended.
the potential for a false market here is huge
while this entire mess remains unresolved.

no RNS, so must assume currently they do still have a nomad.

ADME still listed on cairn’s own website as a current client, just now.

*if* nomad has resigned, i would expect an RNS about that by 6pm this
evening, tho’ ADME is sloppy enough it might slip over into tomorrow
pre-market? - but who knows, maybe ADME is just being extra sloppy
by leaving the nomad off those RNSs by mistake, fits their overall style.

perhaps nomad has given notice, but ADME is spending today frantically
trying to get them to change their mind, hence not immediately disclosing?

never dull ADME (tho’ sadly for investors also never actually profitable either).

hi dan. sure, he might indeed be a genuine, unlucky & gullible
pi, or he might not be. the length of time someone has been
posting about MXO/ADME doesn’t prove it one way or t’other.
this share has been played almost continuously since 2014.

i see that back in may 2019, you posted that “We will be cash
positive by 2020.” … clearly they missed that, by a long, long
way, & yet you seem to remain a fan of the company. strange.

back in spring 2019, you were claiming to hold about 250,000 shares
here, with an average in the neighbourhood of 18p. ( - down from that
peak of 27+ million preconsolidation shares at average just over 0.18p.)

… 18p down to 0.95p on 250,000 shares… (well done osa!)

so not surprising that folk wonder if you are genuine about still liking
ADME, and see you acting as an apologist for this dreadful company.

atb & gl.

so what do you think of the company’s performance over
the five+ years that you claim to have been invested here?

(& why do you think that 4-6 week CPR is still not out
after more than 6 months, if all is fine with barracuda?)

also possible monecor have someone posting, since they
have loads still to get rid of, not to mention those warrants.

but not terribly likely that robertsham or frobertdude
will fess up who they are in IRL, so we’ll never know.

happy to hear your views,
norrab. do please expand?

silly me, & i forget arden, with their farcical ‘research’ notes.

? or maybe luther pendragon, pello, or even possibly align types?
(align pretty nearly got wiped out in 2021, needing chunky bailing, so
not sure tbh whether they are still in game, as far as adme concerned?)

not much bounce today for PRU from friday’s omicron related falls, at
least relative to some other big ftse financials. pru still somewhat unloved.

EB, yes, i agree that these events do call into question what the nomad did
and didn’t know, including e.g. which aspects did it take on trust from ADME
BoD’s say-so, versus were there aspects where the nomad asked to see some
kind of independently verifiable proof of ADME’s claims? the nomad is trying
to *advise* ADME about AIM rules and regulations, and help interpret those
to ADME in relation to particular situations /messages etc., but so far as i
understand it, a nomad does *not* guarantee to be continuously auditing
a company, or independently fact-checking data that a company supplies
to them to try to *catch them out* or attempt some kind of forensic analysis.

an AIM company is meant to act honestly, transparently and in good faith with
its nomad, and if a nomad were to discover that it had been duped by a client
AIM company that would be resignation grounds for most respectable nomads.

(- but i have no particular expertise in AIM regulation or re nomad
operational policies, so am content just to watch & see what unfolds.)

there does seem to be an ongoing issue imho about ADME’s timely
notification of material info to the markets, alongside all the other
issues … e.g. even if ADME is fully confident that NHNL has no good
basis for a claim of £1.75million, I would think that ADME should
have notified its shareholders / market long ago that this dispute
and claim was underway (- which could of course have included
ADME’s protestations of innocence, & reassurances about outcome).

and of course there is still the puzzle about why that 4-6 week CPR for
barracuda is still only at draft stage, at best, more than six months later?

so far as i have seen, ADME has issued no explanation
whatsoever for that ongoing and very long CPR delay.

agree dan, doesn’t seem to move us on much … currently seems, NHNL say,
there’s a big problem, & ADME say, oh no there isn’t (panto season has begun!)
but meanwhile we have no third party adjudicator /judge to rule an outcome.

—> ongoing dispute, clear as mud. … unless there are posters on these boards
who are actually insiders who have read the fine print of the contract(s) signed
by ADME / KONH /Calabar / NHNL, no realistic way to know for sure what the
heck is really going on - which ought to be a serious red flag for any sane pi.

meanwhile, the company’s cash position remains utterly dire, with high
ongoing monthly cashburn and zero cash coming onto ADME’s books (as
the black hole of project debt still swallows up all aje oil revenue) so they
need to do another placing within the next couple of months tops, imv.

a few posters on this board (plus ‘rangenoresources’ on ADVFN) continue to
make positive noises about ADME’s prospects, so maybe ADME should try
a targeted placement to ginksy, frobertdude, mannan, & rangenoresources?

ADME said it had bought 51% of KONH UK ltd.

and so far as i can see, that in itself does
not seem disputed by anyone particularly?

ADME claimed at 28th april ‘21 that this then gave them a controlling interest in a
stake KONH UK owned in NHNL’s risk sharing contract re barracuda/ NW OML 141.

however, it appears from NHNL’s website that NHNL simply don’t agree that
KONH has ever had *any* stake in anything to do with NHNL’s RSC, as they say
that they rejected a “proposal” which ADME/KONH made about that on 28th april.

so *IF* that’s correct, ADME do own 51% of NHNL, but that gives them nothing
from barracuda at all… (i.e. not just that they ‘lost’ it, more that they never
actually had any stake in it.). so when the BoD of ADME spent shareholder money
on buying 51% of KONH UK ltd, what, if anything, was actually owned by KOHN?

i.e. was 51% of KONH actually near worthless when ADME bought a majority stake?

& which individuals benefited from payments ADME made to buy 51% of KONH?

morning frobert. i see you’ve not offered any answer to the question that i
asked you on saturday at 07:40. it’s always interesting to hear from those with
different views, and you appear to remain optimistic about ADME’s prospects,
so i remain curious what your upbeat explanation might be about ADME still not
publishing a barracuda CPR 6 months after they said it should take 4 - 6 weeks?

tia.